From the Guidelines
For a postpartum patient with anemia following a controlled postpartum hemorrhage, intravenous iron supplementation is recommended due to the severe anemia (hemoglobin of 77 g/L) and the need for rapid replenishment of iron stores. According to the most recent and highest quality study 1, intravenous iron is indicated if a patient cannot tolerate oral iron or if blood counts or iron stores do not improve with oral iron supplementation. In this case, the patient's severe anemia and recent postpartum hemorrhage suggest that intravenous iron may be necessary to rapidly replenish iron stores and improve hemoglobin levels.
Some key points to consider when administering intravenous iron include:
- Several different formulations of IV iron are available, but those that can replace iron deficits with 1 to 2 infusions are preferred 1
- Being truly allergic to IV iron is very rare, and most reactions are complement activation-related pseudo-allergy, which can be managed by stopping the infusion and restarting at a slower rate or using corticosteroids 1
- Diphenhydramine should be avoided as it can mask the symptoms of a reaction 1
In terms of oral iron supplementation, oral ferrous sulfate 325 mg (containing 65 mg elemental iron) taken twice daily may be considered if intravenous iron is not available or not tolerated. However, this may not be sufficient to rapidly replenish iron stores in a patient with severe anemia following a postpartum hemorrhage. According to 1, a once daily dose of 50-100 mg of elemental iron may be the best compromise option for initial treatment, but this may not be sufficient for a patient with severe anemia.
It's also important to note that follow-up hemoglobin testing is recommended after 2-4 weeks to assess response to treatment, and that iron supplementation should be continued for at least 3 months to adequately replenish iron stores 1. Additionally, taking iron supplements with vitamin C (such as orange juice) can enhance absorption, while avoiding calcium-containing foods or antacids within 2 hours of the iron supplement can prevent decreased absorption.
From the FDA Drug Label
2 DOSAGE AND ADMINISTRATION
- 1 Recommended Dosage Recommended Dosage for Treatment of Iron Deficiency Anemia For patients weighing 50 kg or more, the recommended dosage is: Injectafer 750 mg intravenously in two doses separated by at least 7 days for a total cumulative dose of 1,500 mg of iron per course In adult patients, Injectafer 15 mg/kg body weight up to a maximum of 1,000 mg intravenously may be administered as a single-dose per course.
The recommended iron supplement for a postpartum patient with anemia (low hemoglobin) following a controlled postpartum hemorrhage (PPH) is ferric carboxymaltose (IV).
- The dosage is 750 mg intravenously in two doses separated by at least 7 days for a total cumulative dose of 1,500 mg of iron per course for patients weighing 50 kg or more.
- Alternatively, 15 mg/kg body weight up to a maximum of 1,000 mg intravenously may be administered as a single-dose per course for adult patients 2. Given the patient's hemoglobin level of 77 g per liter, indicating severe anemia, intravenous iron supplementation is likely necessary to rapidly replenish iron stores.
From the Research
Iron Supplement Recommendations for Postpartum Anemia
- The patient's hemoglobin level is 77 g/L, indicating severe anemia 3.
- Studies suggest that intravenous iron may be a useful alternative to oral iron for treating postpartum anemia, especially if oral iron is not absorbed or tolerated 4, 5, 6.
- Intravenous iron has been shown to reduce fatigue and improve hemoglobin levels more quickly than oral iron 4, 5, 6.
- However, the evidence is very uncertain about the effect of intravenous iron on mortality and anaphylaxis/hypersensitivity 5.
- Oral iron supplementation is also an option, but it may cause more gastrointestinal side effects, such as constipation, compared to intravenous iron 5, 6.
- The choice of iron supplement should be based on individual patient needs and medical history, as well as the severity of the anemia 5, 3, 6.
Key Considerations
- The patient's severe anemia (hemoglobin level of 77 g/L) requires prompt treatment to improve maternal outcomes 3.
- The patient's history of postpartum hemorrhage should be taken into account when selecting an iron supplement, as intravenous iron may be more effective in this population 4, 5.
- Close monitoring of the patient's hemoglobin levels and adverse effects is necessary to adjust the treatment plan as needed 5, 6.
Treatment Options
- Intravenous iron infusion: may be a useful alternative to oral iron, especially if oral iron is not absorbed or tolerated 4, 5, 6.
- Oral iron supplementation: may cause more gastrointestinal side effects, but can still be effective in improving hemoglobin levels 5, 6.
- Red blood cell transfusion: may be considered in severe cases of anemia, but the evidence is very uncertain about its effect on mortality and fatigue 5.